secondary failure
英 [ˈsekəndri ˈfeɪljə(r)]
美 [ˈsekənderi ˈfeɪljər]
网络 二次故障; 继发性失效; 继发无效; 二次失效; 继发故障
双语例句
- Continuous glucose monitoring in subjects with secondary sulfonylureas failure
动态血糖仪监测继发性磺脲类失效血糖漂移的特点 - Intensive insulin therapy in patients with secondary failure of sulfonylurea efficacy
胰岛素强化治疗对磺脲类继发失效患者的疗效 - Evaluation of Determination Results from 3 Kinds of Hematology Analyzers Continuous glucose monitoring in subjects with secondary sulfonylureas failure
三种血细胞分析仪检测结果比较分析动态血糖仪监测继发性磺脲类失效血糖漂移的特点 - Change of Serum Leptin Level in Type 2 Diabetics with Secondary Failure to Sulfonylureas
磺脲类降糖药继发性失效2型糖尿病患者血清瘦素水平的变化 - Effects of Short-term Intensive Insulin Therapy on β Cell Secretion Function in Patients with Secondary Failure of Sulfonylurea
短期胰岛素强化治疗对磺脲类继发性失效患者β细胞功能的影响 - Coolant system leakage, secondary failure.
冷却剂系统的泄露，次级失效。 - Different Therapeutic Regimens for Diabetic Patients with Sulfonylureas Secondary Failure: Cost-Effectiveness Analyses and Evaluation of Life Quality
磺脲类药物继发失效患者不同治疗方案的成本-效果及对生存质量的影响 - Objective To compare the clinical efficacy of insulin and pioglitazone united treatment with single insulin treatment in type 2 diabetes mellitus patients secondary failure to sulforylureas ( Sus).
目的比较胰岛素加吡格列酮联合治疗和单用胰岛素治疗磺脲类继发性失效2型糖尿病患者的疗效。 - Conclusion At the early stage after CMW, there are obstructions to cerebral microcirculation, which induce brain ischemia, hypoxia and secondary failure of cerebral function.
结论CMW后早期出现微循环障碍，导致脑缺血缺氧，引起神经功能障碍； - Clinical effect of glipizide gastrointestinal therapeutic system in treatment of secondary failure to sulfonylurea in noninsulin-dependent diabetes mellitus
格列吡嗪控释片治疗继发性磺脲类降糖药失效2型糖尿病的疗效 - Conclusion There is severe insulin resistance in Type 2 diabetic patients in each stage. The variations of early-phase insulin secretion manifest a vary procedure of obvious deterioration by degrees from the newly diagnosed group to the secondary failure of sulfonylureas group in Type 2 diabetic patients.
结论：2型糖尿病各个阶段均存在严重的胰岛素抵抗，从初发者到继发性磺脲类失效患者，其胰岛β细胞早期分泌相的改变表现为逐级衰退的动态变化过程。 - Clinical effect of Human insulin in secondary failure of sulfonylureas
人胰岛素在磺脲类药物继发失效中的疗效观察 - Studies of Mechanisms of Amylin on Insulin Release from Rat Pancreatic β Cells and Sulfonylureas Secondary Failure
胰淀素对大鼠胰岛β细胞分泌胰岛素及磺脲类药物继发失效机制的研究 - Effects of different combination therapy on secondary failure of sulfonylurea in type 2 diabetes mellitus
不同方式联合药物治疗2型糖尿病继发性失效的疗效探讨 - A Study on insulin release and peripheral sensitivity in non-insulin dependent diabetic with secondary failure to sulfonylureas
继发性磺脲类失效糖尿病患者胰岛素释放及外周胰岛素敏感度的研究 - Clinical Report on Correction of HbAlc Level in Diabetes ⅱ with Secondary Failure of Oral Hypoglycemic Agent by Chinese Herbs
中药纠正口服降糖药物继发失效Ⅱ型糖尿病HbAlc水平的临床报道 - An Observation of Three Therapeutic Methods in the Treatment of Type 2 Diabetes Mellitus with Secondary Failure of Sulfonylurea
继发性磺脲类药物失效的2型糖尿病三种治疗方式的观察与评价 - Objective To evaluate the mechanism of secondary failure to glibenclamide in type 2 diabetic patients and the role of mitochondrial gene position 3243 point mutation ( A → G) in the etiology of secondary failure.
目的了解优降糖继发失效的2型糖尿病患者对不同胰岛素刺激物的反应，探讨线粒体基因第3243位点A→G突变在优降糖继发失效病因学的作用。 - Different responses of β cell to glucagon and glucose in type 2 diabetic patients with secondary failure to glibenclamide
优降糖继发失效患者对葡萄糖及胰升糖素的不同反应 - Efficacy of Novolin R on type 2 diabetes mellitus patients with secondary failure to sulfonylurea
应用诺和灵R治疗磺脲类药物继发失效2型糖尿病的临床观察 - Preliminary appraisal on the causation for secondary failure of sulfonylurea in type 2 diabetes
磺脲类降糖药物继发性失效原因的初步探讨 - Objective To study the therapeutic efficacy of acarbose in addition to sulfonylurea drugs for treatment of type ⅱ Diabetes Mellitus ( NIDDM) with secondary failure to sulfonylurea medication.
目的观察Ⅱ型糖尿病人对磺脲类药物继发性失效加用拜糖平的疗效。 - Objective: Studing the efficacy of the Novolin R in the treatment of type 2 diabetes mellitus patients with secondary failure to sulfonylurea.
目的：观察磺脲类药物继发失效的2型糖尿病应用诺和灵R的疗效。 - Methods One hundred and four type 2 diabetic patients without the secondary failure to sulfonylureas were randomly assigned to glimepiride group or glibenclamide group in ratio 2:1. The whole observation lasted 16 weeks.
方法无磺酰脲类药物继发失效的2型糖尿病患者104例，以2：1的比例随机分入格列美脲组和格列苯脲组，观察时间为16周（8周剂量调整期，8周维持期）。 - Objective To observe the clinical effect of combined use of insulin for secondary failure to sulfonylurea ( SU) treatment.
目的探讨胰岛素联合用药治疗磺脲类（SU）继发性失效临床疗效。 - A preliminary study on the mechanism of secondary failure to sulfonylurea in NIDDM
NIDDM患者继发性磺脲类失效发生机制的初步探讨 - Objective It is to observe the clinical curative effect of Glimepiride and NPH on type 2 diabetic mellitus ( T2DM) patients after the secondary failure of sulfonylurea ( SFS).
目的观察2型糖尿病（T2DM）患者在磺脲类继发失效（SFS）后改用格列美脲联合中效胰岛素（NPH）治疗的临床疗效。 - However, current drugs for type 2 diabetes therapies often have many defects such as secondary failure, side effects and risk of hypoglycemia, so it is important to develop low toxic and long acting anti-diabetes drugs which can improve insulin resistance.
然而，现有的抗2型糖尿病药物多存在着继发性失效、副作用大及容易诱发低血糖等缺陷，因此研发低毒且能改善胰岛素抵抗的长效药物十分必要。